期刊文献+

组织蛋白酶B特异性siRNA对人食管癌EC9706细胞体外侵袭力的抑制作用 被引量:2

Inhibitory effects of siRNA on the invasiveness in vitro of human esophageal carcinoma EC9706 cells
下载PDF
导出
摘要 目的:探讨组织蛋白酶B(CB)特异性siRNA对人食管癌EC9706细胞体外侵袭力的抑制作用。方法:将体外转录合成的针对CB的特异性siRNA设10μmol/L、15μmol/L和20μmol/L3个不同剂量转染人食管癌EC9706细胞,用Boydenchamber体外侵袭实验检测转染前后细胞体外侵袭力的变化。对照组设无关siRNA转染组、空白对照组(转染空脂质体)及正常对照组(不进行任何操作)。结果:和正常对照组相比,特异性siRNA15μmol/L组和20μmol/L组穿越Matrigel胶的细胞数明显减少(P<0.05),而10μmol/L特异性siRNA组、空白对照组和无关siRNA转染组与正常对照组之间差异均无统计学意义(P>0.05)。结论:特异性CBsiRNA能有效抑制人食管癌EC9706细胞的体外侵袭力。 Aim : To investigate the inhibitory effect of specific siRNA of cathepsin B (CB) gene on the invasiveness of human esophageal carcinoma EC9706 cells. Methods: EC9706 cells were transfected with synthesized siRNA of CB gene, and the transfection concentration was 10 μmol/L, 15 μmol/L, and 20 μmol/L. The EC9706 cells transfected with non-specific siRNA, empty liposome, and untransfccted EC9706 cells were used as control. Boyden chamber experiment in vitro was used to detect the invasion ability of EC9706 cells. Results: Compared with normal control, the number of cells traversed Matrigel was decreased obviously in 15 μmol/L specific siRNA group and 20 μmol/L specific siRNA group( P .〈 0.05) ; there were no significant differences in the number of cells traversed Matrigel among 10 μmol/L specific siRNA group, empty liposome group, non-specific siRNA group and normal control group ( P 〉 0.05 ). Conclusion : Specific siRNA can effectively inhibit the invasiveness in vitro of human esophageal carcinoma EC9706 cells.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第1期17-19,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目0624410091
关键词 siRNA 组织蛋白酶B EC9706细胞 转染 侵袭力 siRNA cathepsin B EC9706 cell transfection invasiveness
  • 相关文献

参考文献10

  • 1李美宁,程牛亮.组织蛋白酶B与肿瘤[J].国外医学(肿瘤学分册),2005,32(6):429-432. 被引量:16
  • 2Szpaderska AM,Frankfater A.An intracellular form of cathepsin B contributes to invasiveness in cancer[J].Cancer Res,2001,61(8):3 493
  • 3Fujise N,Nanashim A,Taniguchi Y,et al.Prognostic impact of cathepsin B and matrix metalloproteinasee-9 in pulmonary adenocarcinomas by immunohistochemical study[J].Lung Cancer,2000,27 (1):19
  • 4Yu JY,DeRuiter SL,Turner DL.RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci USA,2002,99(9):6 047
  • 5娄欣,张红,曹学全,孙淼淼,高冬玲,张岚,宋一民,李冰,陈奎生.组织蛋白酶B特异性siRNA对食管癌EC9706细胞组织蛋白酶B基因表达的影响[J].郑州大学学报(医学版),2007,42(1):14-17. 被引量:7
  • 6Stetler-stevenson WG.Type Ⅳ collagenases in tumor invasion and metastasis[J].Cancer Metastasis Rev,1990,9(4):289
  • 7Koblinski JE,Dosescu J,Sameni M,et al.Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B[J].J Biol Chem,2002,277 (35):32 220
  • 8Nishikawa H,Ozaki Y,Nakanishi T,et al.The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer[J].Gynecol Oncol,2004,92 (3):881
  • 9Gondi CS,Lakka SS,Yanamandra N,et al.Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth,invasion,and angiogenesis in gliomas[J].Cancer Res,2004,64(12):4 069
  • 10Lakka SS,Gondi CS,Yanamandra N,et al.Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cel line via RNA interference reduces tumor cell invasion,tumor growth and angiogenesis[J].Oncogene,2004,23(27):4 681

二级参考文献30

  • 1左国庆,张燕,汤为学.奥沙利铂处理人肝癌细胞株HepG2、QGY后凋亡相关基因蛋白的表达[J].重庆医学,2005,34(1):70-72. 被引量:6
  • 2李光明,谢青,史毅,李定国,金由辛.siRNA对HSC结缔组织生长因子的抑制作用[J].上海第二医科大学学报,2005,25(2):116-119. 被引量:4
  • 3王方金,何蕴韶.应用siRNA抑制K562细胞中c-Myc基因的表达[J].解剖学研究,2005,27(1):12-14. 被引量:6
  • 4李美宁,程牛亮.组织蛋白酶B与肿瘤[J].国外医学(肿瘤学分册),2005,32(6):429-432. 被引量:16
  • 5Eijan AM,Sandes EO,Riveros MD,et al. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. Cancer,2003,98 ( 2 ) :262-268.
  • 6Scorilas A, Fotiou S,Tsiambas E ,et al. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. J Biol Chem ,2002,383(7-8) : 1297-1303.
  • 7Hazen LG, Bleeker FE, Lauritzen B, et al. Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem ,2000,48(10):1421-1430.
  • 8Kos J,Werle B,Lah T,et al. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers,2000,15(1):84-89.
  • 9Yan S, Berquin IM, Troen BR, et al. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma DNA. J Cell Biol,2000,19 (2) :79-91.
  • 10Podgorski I,Sloane BF. Cathepsin B and its role(s) in cancer progression. Biochem Soc Symp,2003, (70) :263-276.

共引文献21

同被引文献13

  • 1王金堂,李军,贾光辉,张小卫,张银刚.TGF-β_1中和抗体在预防肌腱黏连中的应用[J].西安交通大学学报(医学版),2007,28(1):83-85. 被引量:7
  • 2FIRE A, XU S, MONTGOMERY MK, et al. Potent and specific genetic interference by double-stranded RNA in caenorhabditiselegans [J]. Nature, 1998, 391(6669) :806-811.
  • 3REYNOLDS A, LEAKE D, BOESE Q, et al. Rational siRNA design for RNA interference[J]. Nat Biotechnol, 2004, 22(3) : 326-330,
  • 4PRUDHOMNE GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations [J]. Lab Invest, 2007, 87(11):1077-1091.
  • 5JSCAFFIDI AK, PETROVIC N, MOODLEY YP, et al. Alpha (v) beta(3) Integrin interacts with the transforming growth factor beta (TGF-beta) type Ⅱ receptor to potentiate the proliferative effects of TGF-betal in living human lung fibroblasts[J]. J Biol Chem, 2004, 279(36) :37726-37733.
  • 6LI AG, LU SL, HAN G, et al. Role of TGFbeta in skin inflammation and carcinogenesis [J]. Mol Carcinog, 2006, 45(6):389-396.
  • 7LEIVONEN SK, KAHARI VM. Transforming growth factorbeta signaling in cancer invasion and metastasis [J]. Int J Cancer, 2007, 121(10) : 2119-2124.
  • 8ALEXANDER B, HEIKE L, RITTNER BR, et al. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras [J]. J Clin Invest, 1997, 99(12): 2842-2850.
  • 9VOLAREVIC M, SMOLIC R, WU CH, et al. Potential role of RNAi in the treatment of HCV infection [J]. Expert Rev Anti Infect Ther, 2007, 5(5) :823-831.
  • 10TAKABATAKE Y, ISAKA Y, MIZUI M, et al. Exploring RNA interference as a therapeutic strategy for renal disease [J]. Gene Ther, 2005, 12(12) :965-973.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部